Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity G Minotti, P Menna, E Salvatorelli, G Cairo, L Gianni Pharmacological reviews 56 (2), 185-229, 2004 | 4310 | 2004 |
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer … JL Zamorano, P Lancellotti, D Rodriguez Munoz, V Aboyans, ... European heart journal 37 (36), 2768-2801, 2016 | 2772 | 2016 |
The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. G Minotti, SD Aust Journal of Biological Chemistry 262 (3), 1098-1104, 1987 | 688 | 1987 |
Anthracycline cardiotoxicity: from bench to bedside L Gianni, EH Herman, SE Lipshultz, G Minotti, N Sarvazyan, DB Sawyer Journal of clinical oncology: official journal of the American Society of …, 2008 | 511 | 2008 |
In Vivo Formation of 8-Epi-Prostaglandin F2α Is Increased in Hypercholesterolemia G Davi, P Alessandrini, A Mezzetti, G Minotti, T Bucciarelli, F Costantini, ... Arteriosclerosis, thrombosis, and vascular biology 17 (11), 3230-3235, 1997 | 467 | 1997 |
An investigation into thee mechanism of citrate FE2+-dependent lipid peroxidation G Minotti, SD Aust Free Radical Biology and Medicine 3 (6), 379-387, 1987 | 332 | 1987 |
The role of iron in the initiation of lipid peroxidation G Minotti, SD Aust Chemistry and Physics of Lipids 44 (2-4), 191-208, 1987 | 330 | 1987 |
Redox cycling of iron and lipid peroxidation G Minotti, SD Aust Lipids 27 (3), 219-226, 1992 | 322 | 1992 |
Role of iron in anthracycline cardiotoxicity: new tunes for an old song? G MINOTTI, G CAIRO, E MONTI The FASEB Journal 13 (2), 199-212, 1999 | 296 | 1999 |
Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis. A Paolicchi, G Minotti, P Tonarelli, R Tongiani, D De Cesare, A Mezzetti, ... Journal of investigative medicine: the official publication of the American …, 1999 | 275 | 1999 |
The role of iron in oxygen radical mediated lipid peroxidation G Minotti, SD Aust Chemico-biological interactions 71 (1), 1-19, 1989 | 255 | 1989 |
Anthracycline cardiotoxicity P Menna, O Gonzalez Paz, M Chello, E Covino, E Salvatorelli, G Minotti Expert opinion on drug safety 11 (sup1), S21-S36, 2012 | 244* | 2012 |
Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated … G Minotti, R Ronchi, E Salvatorelli, P Menna, G Cairo Cancer research 61 (23), 8422-8428, 2001 | 239 | 2001 |
The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage G Cairo, S Recalcati, A Pietrangelo, G Minotti Free Radical Biology and Medicine 32 (12), 1237-1243, 2002 | 232 | 2002 |
Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction S Licata, A Saponiero, A Mordente, G Minotti Chemical research in toxicology 13 (5), 414-420, 2000 | 227 | 2000 |
Cardiotoxicity of antitumor drugs P Menna, E Salvatorelli, G Minotti Chemical research in toxicology 21 (5), 978-989, 2008 | 208 | 2008 |
The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium G Minotti, S Recalcati, A Mordente, G Liberi, AM Calafiore, C Mancuso, ... The FASEB journal 12 (7), 541-552, 1998 | 204 | 1998 |
Sources and role of iron in lipid peroxidation G Minotti Chemical research in toxicology 6 (2), 134-146, 1993 | 193 | 1993 |
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes L Gianni, E Salvatorelli, G Minotti Cardiovascular toxicology 7, 67-71, 2007 | 159 | 2007 |
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms G Minotti, S Recalcati, P Menna, E Salvatorelli, G Corna, G Cairo Methods in enzymology 378, 340-361, 2004 | 156 | 2004 |